Conversely , 5-year event rates were not lower in patients taking statins at 6 months compared with those who were not ( 14.8 % vs 16.3 % ; aHR , 1.23 ; 95 % CI , 0.58-2 .61 ) or in those receiving triple therapy and those who were not ( 14.5 % vs 15.6 % ; aHR , 1.17 ; 95 % CI , 0.71-1 .94 ) .